The Current Ratio as of December 2025 (TTM) for Annexin Pharmaceuticals AB (publ) (ANNX.ST) is 9.32

According to Annexin Pharmaceuticals AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 9.32. This represents a change of 8.59% compared to the average of 8.58 of the last 4 quarters.

Annexin Pharmaceuticals AB (publ) (ANNX.ST) Historical Current Ratio (quarterly & annually)

How has ANNX.ST Current Ratio performed in the past?

The mean historical Current Ratio of Annexin Pharmaceuticals AB (publ) over the last ten years is 4.51. The current 9.32 Current Ratio has changed 20.58% with respect to the historical average. Over the past ten years (40 quarters), ANNX.ST's Current Ratio was at its highest in in the September 2020 quarter at 13.27. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Annexin Pharmaceuticals AB (publ) (ANNX.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Annexin Pharmaceuticals AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Annexin Pharmaceuticals AB (publ) (ANNX.ST) Average Current Ratio

How has ANNX.ST Current Ratio performed in the past?

The current Current Ratio of Annexin Pharmaceuticals AB (publ) (ANNX.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Annexin Pharmaceuticals AB (publ) (ANNX.ST) Current Ratio vs. Peers

How is ANNX.ST’s Current Ratio compared to its peers?

Annexin Pharmaceuticals AB (publ)’s Current Ratio is greater than Isofol Medical AB (publ) (6.80), greater than Lipum AB (publ) (0.62), greater than Initiator Pharma A/S (4.15), greater than IRLAB Therapeutics AB (publ) (1.30), greater than Alzinova AB (publ) (0.20), greater than Enorama Pharma AB (publ) (0.71), greater than Clinical Laserthermia Systems AB (publ) (3.64), greater than Karolinska Development AB (publ) (7.99), greater than Bio-Works Technologies AB (publ) (2.26), greater than Integrum AB (publ) (3.44),

Build a custom stock screener for Annexin Pharmaceuticals AB (publ) (ANNX.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annexin Pharmaceuticals AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Annexin Pharmaceuticals AB (publ) (ANNX.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Annexin Pharmaceuticals AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.